Veran Medical Technologies, Inc.

Veran Medical Technologies, Inc.

Veran Medical Technologies, Inc.

Date Founded



1908 Innerbelt Business Center Drive,St. Louis, MO 63114

Type of Company


Employees (Worldwide)

11 - 50


Medical Products & Equipment
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Medical Support Services

Company Description

Veran Medical Technologies, Inc. designs, develops, and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. The company was founded by Ben Heavrin, Bruce Lynskey, Jerome R. Edwards, and Evan Austill, Jr. in 2005 and is headquartered in St. Louis, MO.

Contact Data
Trying to get in touch with decision makers at Veran Medical Technologies, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Executive Vice President-Operations, Research & Development

Vice President, Application Development & Chief Technical Officer

Global Vice President-Sales

Vice Chairman

Education Manager

Regional Manager



Senior Software Engineer

Board of Directors

Managing Director at Versant Venture Management LLC

President & Chief Executive Officer at Bardy Diagnostics, Inc.

President & Chief Executive Officer at Veran Medical Technologies, Inc.

President, Chief Executive Officer & Director at VentureMed Group, Inc.

Managing Director at River Cities Capital Funds

Executive Chairman at NeuWave Medical, Inc.

Chairman, Chief Scientific Officer & Founder at Glenveigh Medical LLC

Paths to Veran Medical Technologies, Inc.
Potential Connections via
Relationship Science
Veran Medical Technologies, Inc.
Recent Transactions
Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

Details Hidden

Veran Medical Technologies, Inc. raised money in a private placement transaction

Non-Profit Donations & Grants
$500 +
$1,000 - $4,999
Details Hidden

BTG International invests in the life sciences, physical sciences, ageing & neuroscience, multimedia/networking, biopharmaceuticals, nanotechnology, medical devices/diagnostics, optoelectronics, oncology, polymer electronics and semiconductors sectors. The firm seeks early-stage companies with dedicated people, novel technologies, and significant market opportunities. While they focus on seed and early-stage investments, they may consider attractive later-stage investments.

Details Hidden

River Cities Capital Funds focuses on investments in high-growth information technology and healthcare companies in the following industries: software-as-a-service (SaaS), enterprise or infrastructure software, business process outsourcing and devices. The firm invests mainly in expansion-stage companies with revenues of $3 million to $15 million. They may also occasionally make seed stage investments in companies with less than $1 million in trailing 12-month revenue, early-stage investments in companies with $1 million to $3 million in trailing 12-month revenue and late-stage investments in companies with greater than $15 million in trailing 12-month revenue. River Cities targets companies in the Midwestern and Southeastern US.

Details Hidden

Rex Health Ventures (RHV) supports the discovery and development of new treatments, tools, products and services that foster innovation and positively impact the provision of healthcare. The seek to help companies and entrepreneurs bring their products and services into the healthcare market. The firm makes seed and early-stage investments. RHV will consider pre-revenue opportunities, but they generally prefer companies that have at least developed a prototype or beta product. The firm is particularly interested in investments in the following sectors: healthcare information technology, healthcare services, medical devices and BioPharma technologies. Initial investments range from $250,000 to $500,000 and total per company investments range from $500,000 to $2 million. RHV targets investments where there is a realistic possibility of exit within 5 to 7 years.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Veran Medical Technologies, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Veran Medical Technologies, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Veran Medical Technologies, Inc..